Oncology
1 drug is in development for T-cell Lymphoma.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the T-cell Lymphoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| prt2527 | Prelude Therapeutics Inc (PRLD) |
About this indication
T-cell Lymphoma context
Oncology·MeSH: Lymphoma, T-Cell (D016399)
Also known as: Lymphomas, T-Cell
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
Frequently asked questions
How many drugs are in development for T-cell Lymphoma?
BioSniper tracks 1 drug in development for T-cell Lymphoma across 1 company.
How many clinical trials target T-cell Lymphoma?
There are 7 clinical trials targeting T-cell Lymphoma tracked by BioSniper.
What is the prevalence of T-cell Lymphoma?
The estimated prevalence of T-cell Lymphoma is approximately 56.0 per 100,000 population.